Tweet
<TABLE cellSpacing=0 cellPadding=0 border=0><TBODY><TR><TD class=storyTD vAlign=top>WFU To Study Affects Of H1N1 Vaccine On Asthmatics
Study Funded By National Institutes of Health
POSTED: 1:50 pm EDT October 19, 2009
UPDATED: 2:22 pm EDT October 19, 2009
</TD></TR></TBODY></TABLE>
WINSTON-SALEM --
The Wake Forest University School of Medicine will be conducting a study on the affects of the H1N1 flu vaccine on asthmatics, particularly those with severe asthma.
The study is important because people who have asthma may be particularly at risk for infection with the H1N1 influenza virus, officials said.
The study is being funded by the National Institutes of Health.
"This is an extremely important study sponsored by the NIH that will determine how we can safely and effectively immunize asthmatics for H1N1 influenza, since asthmatics are at a high risk for developing more severe H1N1 infections," said Dr. Eugene R. Bleecker, a professor of internal medicine at the Wake Forest University School of Medicine.
The vaccine to be used in the trial contains inactivated 2009 H1N1 influenza virus, and therefore cannot cause anyone to become infected with the virus, officials said.
Study Funded By National Institutes of Health
POSTED: 1:50 pm EDT October 19, 2009
UPDATED: 2:22 pm EDT October 19, 2009
</TD></TR></TBODY></TABLE>
WINSTON-SALEM --
The Wake Forest University School of Medicine will be conducting a study on the affects of the H1N1 flu vaccine on asthmatics, particularly those with severe asthma.
The study is important because people who have asthma may be particularly at risk for infection with the H1N1 influenza virus, officials said.
The study is being funded by the National Institutes of Health.
"This is an extremely important study sponsored by the NIH that will determine how we can safely and effectively immunize asthmatics for H1N1 influenza, since asthmatics are at a high risk for developing more severe H1N1 infections," said Dr. Eugene R. Bleecker, a professor of internal medicine at the Wake Forest University School of Medicine.
The vaccine to be used in the trial contains inactivated 2009 H1N1 influenza virus, and therefore cannot cause anyone to become infected with the virus, officials said.
